[1]
W. Krajewski, “Does Mantoux Test Result Predicts BCG Immunotherapy Efficiency and Severe Toxicity in Non-Muscle Invasive Bladder Cancer”, Urol J, vol. 16, no. 5, pp. 458–462, Oct. 2019.